{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:51:58Z","timestamp":1793260318879,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011636","name":"Chinese Academy of Medical Sciences & Peking Union Medical College State Key Laboratory of Bioactive Substance and Function of N","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.biomaterials.2021.120944","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T05:38:05Z","timestamp":1623044285000},"page":"120944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Effective oral delivery of Exenatide-Zn2+ complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9119-0019","authenticated-orcid":false,"given":"Ying","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6858-2778","authenticated-orcid":false,"given":"Qiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingji","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2021.120944_bib1","year":"2019"},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2021.120944_bib2","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/j.jcjd.2017.10.037","article-title":"Type 2 diabetes in children and adolescents","volume":"42","author":"Panagiotopoulos","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.biomaterials.2021.120944_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF00429088","article-title":"Glucagon-like peptide-l, a new hormone of the entero-insular axis","volume":"35","author":"Orskov","year":"1992","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120944_bib4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120944_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2613.2011.00767.x","article-title":"Classification and functions of enteroendocrine cells of the lower gastrointestinal tract","volume":"92","author":"Gunawardene","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120944_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/meta.2001.22519","article-title":"Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro","volume":"50","author":"Parkes","year":"2001","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120944_bib7","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.apsb.2019.01.004","article-title":"Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides\/proteins","volume":"9","author":"Han","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120944_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/dia.2019.0185","article-title":"Oral Semaglutide: a review of the first oral glucagon-like peptide 1 receptor agonist","volume":"22","author":"Bucheit","year":"2020","journal-title":"Diabetes Technol. Therapeut."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120944_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/CS20150154","article-title":"The regulation of function, growth and survival of GLP-1-producing L-cells","volume":"130","author":"Kuhre","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120944_bib10","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1021\/acsnano.8b04315","article-title":"Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2021.120944_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2018.12.028","article-title":"Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model","volume":"294","author":"Suzuki","year":"2019","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120944_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.biomaterials.2021.120944_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4155\/tde.13.153","article-title":"Polysialic acid: overcoming the hurdles of drug delivery","volume":"5","author":"Bader","year":"2014","journal-title":"Ther. Deliv."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.120944_bib14","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.7150\/thno.19863","article-title":"High-yield synthesis of monomeric LMWP(CPP)-siRNA covalent conjugate for effective cytosolic delivery of siRNA","volume":"7","author":"Ye","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2021.120944_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.05.056","article-title":"Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide","volume":"193","author":"He","year":"2014","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.biomaterials.2021.120944_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/10826068.2015.1135463","article-title":"Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins","volume":"46","author":"Wu","year":"2016","journal-title":"Prep. Biochem. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2021.120944_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijpharm.2016.10.051","article-title":"Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation","volume":"515","author":"Zhang","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2021.120944_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2016.10.002","article-title":"The interaction of protamine nanocapsules with the intestinal epithelium: a mechanistic approach","volume":"243","author":"Thwala","year":"2016","journal-title":"J. Contr. Release"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2021.120944_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijpharm.2018.05.055","article-title":"The use of low molecular weight protamine to enhance oral absorption of exenatide","volume":"547","author":"Zhang","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2021.120944_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","article-title":"Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates","volume":"233","author":"Sheng","year":"2016","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.biomaterials.2021.120944_bib21","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.biomaterials.2013.01.013","article-title":"A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2021.120944_bib22","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.biomaterials.2010.12.044","article-title":"The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo","volume":"32","author":"Nguyen","year":"2011","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.biomaterials.2021.120944_bib23","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1074\/jbc.M506710200","article-title":"Deoxycholic acid induces intracellular signaling through membrane perturbations","volume":"281","author":"Jean-Louis","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120944_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ijpharm.2015.10.078","article-title":"Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin","volume":"496","author":"Zhang","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2021.120944_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2005.06.007","article-title":"Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids","volume":"300","author":"Gregoriadis","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2021.120944_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/bm1008603","article-title":"Polysialic acid-based micelles for encapsulation of hydrophobic drugs","volume":"12","author":"Bader","year":"2011","journal-title":"Biomacromolecules"},{"issue":"Pt A","key":"10.1016\/j.biomaterials.2021.120944_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejpb.2014.12.021","article-title":"In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration","volume":"97","author":"Inchaurraga","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2021.120944_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12989-015-0085-5","article-title":"Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter?","volume":"12","author":"Hinkley","year":"2015","journal-title":"Part. Fibre Toxicol."},{"issue":"Pt B","key":"10.1016\/j.biomaterials.2021.120944_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.addr.2016.06.006","article-title":"Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs","volume":"106","author":"Griffin","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2021.120944_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2018.02.045","article-title":"Oral insulin delivery, the challenge to increase insulin bioavailability: influence of surface charge in nanoparticle system","volume":"542","author":"Czuba","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2021.120944_bib31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.120944_bib32","doi-asserted-by":"crossref","first-page":"G978","DOI":"10.1152\/ajpgi.00379.2004","article-title":"Cholesterol modulates human intestinal sodium-dependent bile acid transporter","volume":"288","author":"Alrefai","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2021.120944_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2007.08.051","article-title":"Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles","volume":"350","author":"Yin","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.120944_bib34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3382\/ps.2007-00430","article-title":"Kinetics of zinc absorption by in situ ligated intestinal loops of broilers involved in zinc transporters","volume":"87","author":"Yu","year":"2008","journal-title":"Poultry Sci."},{"key":"10.1016\/j.biomaterials.2021.120944_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.phrs.2016.07.042","article-title":"Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat","volume":"111","author":"Amadio","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biomaterials.2021.120944_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular targeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2021.120944_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","article-title":"Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery","volume":"151","author":"Fan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.120944_bib38","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Lysosomotropic agents","volume":"18","author":"Duve","year":"1974","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120944_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.12235","article-title":"Modeling type 2 diabetes in rats using high fat diet and streptozotocin","volume":"5","author":"Skovso","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.biomaterials.2021.120944_bib40","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2337\/diacare.20.12.1822","article-title":"Nonfastinq plasma glucose is a belter marker of diabetic control than fasting plasma glucose in type 2 diabetes","volume":"20","author":"Avignon","year":"1997","journal-title":"Diabetes Care"},{"issue":"32","key":"10.1016\/j.biomaterials.2021.120944_bib41","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1016\/j.biomaterials.2013.07.021","article-title":"Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT","volume":"34","author":"Chuang","year":"2013","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2021.120944_bib42","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.2337\/db09-1886","article-title":"In vivo expression of HGF\/NK1 and GLP-1 from dsAAV vectors enhances pancreatic -cell proliferation and improves pathology in the db\/db mouse model of diabetes","volume":"59","author":"Gaddy","year":"2010","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120944_bib43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/j.gastro.2018.11.017","article-title":"Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery","volume":"156","author":"Albaugh","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2021.120944_bib44","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/diabetes.54.8.2294","article-title":"Mechanisms of compensatory-cell growth in insulin-resistant rats","volume":"54","author":"Jetton","year":"2005","journal-title":"DIABETES"},{"issue":"2","key":"10.1016\/j.biomaterials.2021.120944_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17425255.2018.1420160","article-title":"Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes","volume":"14","author":"Molina Vega","year":"2018","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.120944_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","article-title":"Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?","volume":"54","author":"Nauck","year":"2011","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120944_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1573399810666140707092506","article-title":"Effect of GLP-1 based therapies on diabetic dyslipidemia","volume":"10","author":"Patel","year":"2014","journal-title":"Curr. Diabetes Rev."},{"issue":"11","key":"10.1016\/j.biomaterials.2021.120944_bib48","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00125-015-3727-0","article-title":"Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice","volume":"58","author":"Kooijman","year":"2015","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.120944_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2016.05.086","article-title":"GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR pathway","volume":"476","author":"He","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.120944_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/dom.12026","article-title":"Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks","volume":"15","author":"Bergenstal","year":"2013","journal-title":"Diabetes Obes. Metabol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221003008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221003008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:09:27Z","timestamp":1758906567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221003008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":50,"alternative-id":["S0142961221003008"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120944","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective oral delivery of Exenatide-Zn2+ complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120944"}}